Zydus receives USFDA's final approval for Indomethacin Suppository with competitive generic therapy designation
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Take proper precautions and seek timely treatment!
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
This product will be launched through Granules Consumer Health (GCH) division
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
PEEK brings a new quality to dental care for patients
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Supply readiness follows months of manufacturing to ensure timely and ample supply
Subscribe To Our Newsletter & Stay Updated